Kazia Therapeutics (KZIA) Receivables - Doubtful (2019)
Kazia Therapeutics (KZIA) posted Receivables - Doubtful of -$11744.8 for Q2 2019.
Kazia Therapeutics (KZIA) Receivables - Doubtful (2019) Analysis & Trends
Kazia Therapeutics' Receivables - Doubtful history runs 1 years deep, the most recent figure standing at -$11744.8 for Q2 2019.
- Quarterly Receivables - Doubtful changed N/A year-over-year to -$11744.8 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$11744.8 (changed N/A YoY) and the FY2019 annual result came in at -$11744.8, changed N/A from the prior year.
- Receivables - Doubtful was -$11744.8 for Q2 2019 at Kazia Therapeutics.
- Across five years, Receivables - Doubtful topped out at -$11744.8 in Q2 2019 and bottomed at -$11744.8 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Doubtful (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -11,744.82 |
| Jun 30, 2019 | -11,744.82 |